This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

The Fleecing of Star Scientific

GLENN ALLEN, Va. ( TheStreet) -- Star Scientific (STSI) wants retail investors to believe a dire cash crisis has been averted by the generosity of its CEO Johnnie Williams and some long-term shareholders. In reality, the financing announced Friday is just another fleece job.

The peddler of over-the-counter nutritional supplements raised $20 million in much-needed cash through the exercise of warrants held by Williams and "several long term shareholders," Star Scientific said in a regulatory filing.

Williams will also reduce his salary to $1 per month until Star Scientific achieves profitability, the company said.

Last week, Star warned that its $10.5 million in working capital was only sufficient to keep the company afloat into the first quarter 2013. The $20 million infusion will probably keep Star's lights burning bright for an additional three or four quarters.

The financing, however, is a financial windfall for the select and unnamed shareholders involved. The exercise price of the warrants was cut drastically, which means millions of dollars that should have been deposited into Star Scientific's bank account ended up instead lining the pockets of these privileged shareholders.

The original exercise price of the 18.5 million warrants was $2.71 per share. Under terms of the financing announced Friday, the exercise price of these warrants was cut to $1 per share.

Instead of raising $50 million, Star Scientific raised $18.5 million when these warrants were exercised.

Even more egregious, the reduced $1-per-share price of the warrants is a 38% discount to Star Scientific's closing stock price of $1.61 per share on Thursday. That translates into an $11.3 million profit (on paper) for the investors who were able to exercise their warrants at the deeply discounted price.

Let's repeat: $11.3 million in profit taking from Star Scientific and given to a select group of "long term shareholders," who by their actions, believe the company is worth $1 per share.

Star Scientific shares were up 9% to $1.78 in Friday's pre-market trading, which means the pile of money handed over to these very lucky shareholders has grown even larger.

As for Star Scientific's CEO Johnnie Williams, let's not shed a tear for his reduced salary since he was being paid $1 million per year in salary. Williams also exercised 1.5 million warrants priced at $1.50, or an 11% discount to the company's stock price at Thursday's close. Not exactly a hardship case for Williams.

-- Reported by Adam Feuerstein in Boston.

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
STSI $0.21 3.14%
AAPL $126.84 -1.30%
FB $81.49 0.74%
GOOG $575.44 0.36%
TSLA $203.14 0.35%

Markets

DOW 18,122.98 +26.08 0.14%
S&P 500 2,101.93 +3.40 0.16%
NASDAQ 4,985.0310 +17.89 0.36%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs